Investigation Report on China Cattle Encephalon Glycoside and Ignotin Market, 2010-2019
According to WHO, such noncommunicable diseases as cardiovascular disease, cancer, chronic respiratory disease, diabetes have become severe threats to human health in the 21st century. According to the Report on Cardiovascular Diseases in China (2013), cardiovascular disease is the leading killer of Chinese people with 3.5 million dying from it each year. Two in every five deaths are caused by cardiovascular disease and every ten seconds witnesses the death of one people caused by cardiovascular disease. According to statistics, by 2020, the number of people dying from cardiovascular disease will reach 4 million each year. But the growth of mortality of cardiovascular disease has slowed down since 2009. Featuring high mortality, disability, incidence and medical risk, cardiovascular disease has become a major public health issue in China. According to ADI-China, the incidence of dementia reaches up to 5.6% among people aged above 65 and over 25% among those aged above 85. And the number of new cases is about 0.3 million each year. In 2014, the incidence of dementia in China was equal to that in the world with about 10 million Chinese suffering from it.
After purchasing Dupromise Medicine Co., Ltd, Jilin Sihuan Pharmaceutical Co., Ltd got the production license of cattle encephalon glycoside and ignotin injection. Cattle encephalon glycoside and ignotin develops fast after entering China with sales value reaching CNY 681 million in 2014 and CAGR during the period of 2010-2014 surpassing 110%. As members of Sihuan Pharmaceutical Holdings Group Ltd, Jilin Sihuan Pharmaceutical Co., Ltd and Jilin Sichang Pharmaceutical Co., Ltd dominate the market with the former having a higher market share of nearly 90% for sales value in 2014. With aging population in China, the incidences of cardiovascular disease and dementia grow year by year. Therefore, cattle encephalon glycoside and ignotin is expected to enjoy a vast demand in China.
Readers can get at least the following information through this report:
market size of cattle encephalon glycoside and ignotin in China
competitive landscape of cattle encephalon glycoside and ignotin market in China
price of cattle encephalon glycoside and ignotin made by different enterprises in China
market outlook of cattle encephalon glycoside and ignotin in China
The author suggests the following groups of people purchase this report:
manufacturers of anti-dementia drugs
investors/research institutions interested in Chinese medicine market
-any interest in Chinese medicine market, please contact CRI for customized survey service
Please Note: All reports from China Research and Intelligence are written in Chinese, then translated to English. This process takes approximately 5 business days from the date the order is placed